Frag 176-191

Fragment 176-191 is a synthetic peptide sequence of human growth hormone that is associated with lower blood sugar levels, fat burning, cartilage regeneration, and more.

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

Compound Overview

Class of Compound:

Peptide

Mechanism of Action:

Fragment 176-191 exhibits lipolytic activity similar to that of growth hormone, without the accompanying hyperglycemia. The sequence does not compete for the HGH receptors and can induce fat metabolism while increasing energy consumption, fat oxidation, and the generation of myoblasts.

Notable Studies:

Also Known As:

Somatotropin (176-191), 66004-57-7, human growth hormone (176-191), hGH (176-191), DTXSID10216216, hGH Fragment 176-191

Research Applications:

Fat loss
Reduced insulin sensitivity
Cartilage regeneration

Risks:

Limited human studies
Mechanism of action not fully understood
Injection-related side effects

Chemical Structure

Customer Reviews

Rated 0 out of 5

0 reviews

Rated 5 out of 5

0

Rated 4 out of 5

0

Rated 3 out of 5

0

Rated 2 out of 5

0

Rated 1 out of 5

0

Reviews

Clear filters

There are no reviews yet.

Be the first to review “Frag 176-191”